RedHill Biopharma reports that the opaganib mechanism is not affected by viral spike protein…
RedHill Biopharma reports that the opaganib mechanism is unaffected by viral spike protein mutations, including Omicron mutations, from The Mountaineer
Browsing Tag
Opaganib
RedHill Biopharma Reports Top-Line Data From Phase 2/3 Study Of Opaganib In Serious COVID-19…
RedHill Biopharma Reports Top Line Data From Phase 2/3 Study Of Opaganib In Serious COVID-19 Patients Johnson City Press (Subscription)
RedHill Biopharma announces presentation of positive oral opaganib Phase 2 data in COVID-19 –…
RedHill Biopharma Announces Presentation of Positive Phase 2 Data for Oral Opaganib in COVID-19
RedHill Biopharma Completes Oral Opaganib Phase 2/3 COVID-19 Study Recruitment – Johnson City…
RedHill Biopharma Completes Oral Opaganib Phase 2/3 COVID-19 Trial Registration Johnson City Press (Subscription)
RedHill Biopharma Receives U.S. Patent Filing Grants for Opaganib and RHB-107 for COVID-19 –…
RedHill Biopharma Receives U.S. Patent Filing Approvals for Opaganib and RHB-107 for COVID-19 PRNewswire
RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with…
RedHill Biopharma's COVID-19 Phase 2/3 study of opaganib passes fourth DSMB review with unanimous recommendation to continue BioSpace